Esperion Therapeutics (NASDAQ:ESPR) Receives “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) in a research report report published on Wednesday morning,Benzinga reports. The firm currently ...
ETF Daily News7h
HC Wainwright Forecasts Strong Price Appreciation for Iris Energy (NASDAQ:IREN) Stock
Iris Energy (NASDAQ:IREN – Free Report) had its price objective boosted by HC Wainwright from $13.00 to $16.00 in a research ...
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
To access the live webcast of the fireside chat, please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a ...
Behind the Scenes of SoundHound AI's Latest Options Trends
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoundHound AI ...
Looking At Cipher Mining's Recent Unusual Options Activity
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Fintel on MSN4d
HC Wainwright & Co. Downgrades Cassava Sciences (SAVA)
Fintel reports that on November 26, 2024, HC Wainwright & Co. downgraded their outlook for Cassava Sciences (NasdaqCM:SAVA) ...
Fintel on MSN5d
HC Wainwright & Co. Downgrades Mainz Biomed N.V. (MYNZ)
Fintel reports that on November 25, 2024, HC Wainwright & Co. downgraded their outlook for Mainz Biomed N.V. (NasdaqCM:MYNZ) ...